SMA HCP News November Round-up: Risdiplam, Early Treatment, NURTURE Study
While the biggest news this week may be the success of the drug risdiplam in improving motor function in a late stage clinical trial on patients with SMA types 2 and 3,1 other important data on SMA have also been published in recent weeks. Below is a roundup of new…